Skip to main content
Log in

Subclinical Cushing’s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis

  • Meta-Analysis
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

The purpose of this study was to systematically review the literature for studies that have investigated possible differences in the prevalence of subclinical Cushing’s syndrome (SCS) and related clinical implications between patients with unilateral (UAI) and bilateral adrenal incidentalomas (BAI) and to meta-analyze the best evidence available. Electronic databases PubMed and EMBASE were systematically searched. Main study outcome was the prevalence of SCS in patients with UAI and BAI. Secondary outcomes were the prevalence of obesity, diabetes, glucose intolerance, hypertension, dyslipidemia, and osteoporosis in patients with UAI and BAI. Risk differences (RD) or mean differences (MD) and 95 % confidence intervals (CIs) were calculated. Meta-analysis was conducted using Review Manager (RevMan 5.3). Six studies were included in the meta-analysis involving in total 1239 patients, 968 with UAI, and 271 with BAI. Patients with UAI had lower prevalence of SCS compared with those with BAI [RD (95 % CI) −0.13 (−0.22 to −0.05), I 2 = 42 %]. The mass diameter of UAI did not differ from BAI (the size of the largest lesion) [MD (95 % CI) −0.45 (−1.09 to 0.19), I 2 = 91 %]. The prevalence of obesity [MD (95 % CI) 0.42 (−0.53 to 1.37), I 2 = 4 %], diabetes [RD (95 % CI) −0.04 (−0.11 to 0.04), I 2 = 0 %], hypertension [RD (95 % CI) 0.00 (−0.18 to 0.18), I 2 = 75 %], and dyslipidemia [RD (95 % CI) −0.02 (−0.16 to 0.13), I 2 = 50 %] did not differ between UAI and BAI. The present meta-analysis provided evidence that patients with BAI present a higher prevalence of SCS compared to patients with UAI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. R.T. Kloos, M.D. Gross, I.R. Francis, M. Korobkin, B. Shapiro, Incidentally discovered adrenal masses. Endocr. Rev. 16, 460–484 (1995)

    CAS  PubMed  Google Scholar 

  2. C. Davenport, A. Liew, B. Doherty, H.H. Win, H. Misran, S. Hanna, D. Kealy, F. Al-Nooh, A. Agha, C.J. Thompson, M. Lee, D. Smith, The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 40, 80–83 (2011)

    Article  CAS  PubMed  Google Scholar 

  3. S. Bovio, A. Cataldi, G. Reimondo, P. Sperone, S. Novello, A. Berruti, P. Borasio, C. Fava, L. Dogliotti, G.V. Scagliotti, A. Angeli, M. Terzolo, Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J. Endocrinol. Invest. 29, 298–302 (2006)

    Article  CAS  PubMed  Google Scholar 

  4. J.H. Song, F.S. Chaudhry, W.W. Mayo-Smith, The incidental adrenal mass on CT: prevalence of adrenal disease in 1,029 consecutive adrenal masses in patients with no known malignancy. AJR Am. J. Roentgenol. 190, 1163–1168 (2008)

    Article  PubMed  Google Scholar 

  5. L. Barzon, N. Sonino, F. Fallo, G. Palu, M. Boscaro, Prevalence and natural history of adrenal incidentalomas. Eur. J. Endocrinol. 146, 61–66 (2002)

    Article  CAS  PubMed  Google Scholar 

  6. M. Terzolo, S. Bovio, G. Reimondo, A. Pia, G. Osella, G. Borretta, A. Angeli, Subclinical Cushing’s syndrome in adrenal incidentalomas. Endocrinol. Metab. Clin. N. Am. 34, 423–439 (2005)

    Article  Google Scholar 

  7. M. Reincke, J. Nieke, G.P. Krestin, W. Saeger, B. Allolio, W. Winkelmann, Preclinical Cushing’s syndrome in “adrenal incidentalomas”: comparison with adrenal Cushing’s syndrome. J. Clin. Endocrinol. Metab. 75, 826–832 (1992)

    CAS  PubMed  Google Scholar 

  8. R. Rossi, L. Tauchmanova, A. Luciano, M. Di Martino, C. Battista, L. Del Viscovo, V. Nuzzo, G. Lombardi, Subclinical Cushing’s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metab. 85, 1440–1448 (2000)

    CAS  PubMed  Google Scholar 

  9. F. Mantero, M. Terzolo, G. Arnaldi, G. Osella, A.M. Masini, A. Ali, M. Giovagnetti, G. Opocher, A.A. Angeli, Survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology. J. Clin. Endocrinol. Metab. 85, 637–644 (2000)

    CAS  PubMed  Google Scholar 

  10. E. Vassilatou, A. Vryonidou, S. Michalopoulou, J. Manolis, J. Caratzas, C. Phenekos, I. Tzavara, Hormonal activity of adrenal incidentalomas—results from a long term follow-up study. Clin. Endocrinol. (Oxf.) 70, 674–679 (2009)

    Article  CAS  Google Scholar 

  11. D. Aron, M. Terzolo, T.J. Cawood, Adrenal incidentalomas. Best Pract. Res. Clin. Endocrinol. Metab. 26, 69–82 (2012)

    Article  PubMed  Google Scholar 

  12. R. Giordano, F. Guaraldi, R. Berardelli, I. Karamouzis, V. D’Angelo, E. Marinazzo, A. Picu, E. Ghigo, E. Arvat, Glucose metabolism in patients with subclinical Cushing’s syndrome. Endocrine 41, 415–423 (2012)

    Article  CAS  PubMed  Google Scholar 

  13. K. Duan, H.K. Gomez, O. Mete, Clinicopathological correlates of adrenal Cushing’s syndrome. J. Clin. Pathol. 68, 175–186 (2015)

    Article  CAS  PubMed  Google Scholar 

  14. A. Patocs, M. Toth, C. Barta, M. Sasvari-Szekely, I. Varga, N. Szucs, C. Jakab, E. Glaz, K. Racz, Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur. J. Endocrinol. 147, 349–355 (2002)

    Article  CAS  PubMed  Google Scholar 

  15. D.A. Vassiliadi, G. Ntali, E. Vicha, S. Tsagarakis, High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol. (Oxf.) 74, 438–444 (2011)

    Article  Google Scholar 

  16. I. Androulakis, G. Kaltsas, A. Markou, E. Tseniklidi, P. Kafritsa, T. Pappa, L. Papanastasiou, G. Piaditis, The functional status of incidentally discovered bilateral adrenal lesions. Clin. Endocrinol. (Oxf.) 75, 44–49 (2011)

    Article  CAS  Google Scholar 

  17. H. Olsen, E. Nordensrom, A. Bergenfelz, U. Nyman, S. Valdemarsson, E. Palmqvist, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 42, 164–173 (2012)

    Article  CAS  PubMed  Google Scholar 

  18. V. Morelli, S. Palmieri, A.S. Salcuni, C. Eller-Vainicher, E. Cairoli, V. Zhukouskaya, A. Scillitani, P. Beck-Peccoz, I. Chiodini, Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. Eur. J. Endocrinol. 168, 235–241 (2013)

    Article  CAS  PubMed  Google Scholar 

  19. E. Vassilatou, A. Vryonidou, D. Ioannidis, S.A. Paschou, M. Panagou, I. Tzavara, Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. Eur. J. Endocrinol. 171, 37–45 (2014)

    Article  CAS  PubMed  Google Scholar 

  20. M. Viswanathan, N.D. Berkman, D.M. Dryden, L. Hartling, Assessing Risk of Bias and Confounding in Observational Studies of Interventions or Exposures: Further Development of the RTI Item Bank. Methods Research Report (Prepared by RTI–UNC Evidence-based Practice Center under Contract No. 290-2007-10056-I). AHRQ Publication No. 13-EHC106-EF (Agency for Healthcare Research and Quality, Rockville, 2013)

  21. R. DerSimonian, N. Laird, Meta-analysis in clinical trials. Control Clin. Trials 7, 177–188 (1986)

    Article  CAS  PubMed  Google Scholar 

  22. M. Egger, G. Davey Smith, D. Altman, Systematic Reviews in Health Care: Meta-analysis in Context (BMJ Publishing Group, London, 2001)

    Book  Google Scholar 

  23. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6, e1000097 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  24. S. Yener, H. Yilmaz, T. Demir, M. Secil, A. Comlekci, DHEAS for the prediction of subclinical Cushing’s syndrome: perplexing or advantageous? Endocrine 48, 669–676 (2015)

    Article  CAS  PubMed  Google Scholar 

  25. W.F. Young Jr, H. du Plessis, G.B. Thompson, C.S. Grant, D.R. Farley, M.L. Richards, D. Erickson, A. Vella, A.W. Stanson, J.A. Carney, C.F. Abboud, P.C. Carpenter, The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J. Surg. 32, 856–862 (2008)

    Article  PubMed  Google Scholar 

  26. M. Terzolo, G. Osella, A. Ali, G. Borretta, F. Cesario, P. Paccotti, A. Angeli, Subclinical Cushing’s syndrome in adrenal incidentaloma. Clin. Endocrinol. (Oxf.) 48, 89–97 (1998)

    Article  CAS  Google Scholar 

  27. G.P. Bernini, A. Moretti, C. Oriandini, M. Bardini, C. Taurino, A. Salvetti, Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br. J. Cancer 92, 1104–1109 (2005)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stavroula A. Paschou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paschou, S.A., Kandaraki, E., Dimitropoulou, F. et al. Subclinical Cushing’s syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis. Endocrine 51, 225–235 (2016). https://doi.org/10.1007/s12020-015-0776-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-015-0776-6

Keywords

Navigation